Thermo Fisher has outlaid $2bn to expand manufacturing and development in the US, joining the long list of companies directing resources to domestic operations as ongoing US tariffs risk destabilising ...

Thermo Fisher Scientific, a Massachusetts-based CDMO giant, inked a collaboration deal with biotech startup Mirai Bio to ...

Thermo Fisher is facing macro headwinds, but execution remains solid. Click here to read why I’m maintaining my Buy rating ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will invest an additional $2 billion in the United States over the next four years ...

Thermo Fisher Scientific has introduced the Applied Biosystems MagMAX Pro HT NoSpin Plasmid MiniPrep Kit to address the ...

We recently published a list of the 10 Best Strong Buy Stocks To Buy Right Now. In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE:TMO) stands against the other ...

Thermo Fisher CEO Marc Casper noted strong performance in Q1 2025, delivering $10.36 billion in revenue. Adjusted EPS grew 1% to $5.15. Adjusted operating income was $2.27 billion, with an ...

(RTTNews) - Thermo Fisher Scientific Inc. (TMO) announced Thursday its plan to invest an additional $2 billion in the United States over the next four years to boost manufacturing capacity.

Thermo Fisher will provide upstream expansion of hMSCs and downstream purification of MSCs and MSC-derived exosomes, and drug manufacturing.

Headquartered in Waltham, Massachusetts, Thermo Fisher employed nearly 2,300 employees on its research campus as of last ...

Shares of Thermo Fisher Scientific Inc. TMO rallied 7.31% to $432.59 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 3.26% ...

In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE ... Considering the broadening versus the Mag 7, this year’s outperformance is pretty dramatic.